Name: Teleoncology Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Creator: DataM Intelligence
Published: Tue May 07 2024 11:01:43 GMT+0530 (India Standard Time)
License: https://www.datamintelligence.com/terms-conditions
Keywords: Teleoncology Market

Teleoncology Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Teleoncology Market is segmented By Component (Software, Hardware, Services) By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Bladder Cancer, Liver Cancer, Others) By Application (Precision Medicine, Patient Care Management, Research &amp; Development, Clinical Trials, Diagnosis &amp; Treatment Decision Making, Data Management, Others) By End-User (Hospitals &amp; Diagnostics Imaging Centers, Pharma &amp; Biotech Companies, Academic and Research Institutes, Contract Research Organizations, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global teleoncology market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Teleoncology market involves the use of advanced computing and information technology for improved cancer care. It enables remote delivery of cancer care services such as diagnosis, treatment planning, monitoring etc using software, automation,&nbsp; AI, big data analytics and other digital technologies. Teleoncology includes various software for the cancer care that helps the patient provides a full collection of tools to help manage cancer care.

Teleoncology technologies facilitate a cooridinated and faster exchange of patient data between specalists to identify at risk individual early and personalized treatment regimens. They empower physicians to make data-driven clinical decisions by providing actionable insights. The market has gained traction owing to the rising prevalence of cancer globally, the need for cancer diagnosis and treatment, technological advancements and increasing research and clinical trials in oncology.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size&nbsp;
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Component, Cancer type, Application and End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report - <a href="https://www.datamintelligence.com/download-sample/teleoncology-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers</h3>

Advancemenst in the AI &amp; big data analytics

Technological advancements in the AI, big data analytics and machine learning are driving the teleoncology market. The technologies are enabling&nbsp; analysis of multidimensional cancer&nbsp; data sets to obtain actionable insights for precision care. For instance, AI can&nbsp; analyze digital pathology images to identify cancerous cells. Big data analytics facilitates evidence based treatment&nbsp; decision by discovering associations in disparate oncology data.&nbsp;

Major key players in the market are integtating AI with big data anlytics facilities into teleoncology platform. For instance, in October 2021, Keninklijke Philips N.V. launched its intellisite pathlogy solution with AI enabled agumented reality for better cancer diagnosis. AI and big data analytics improve the functionality of teleoncology technologies.

Moreover, a major trend in the teleoncology market is the cloud based oncology informatics for conviences and flexibility access. These platforms allow easy sharing of patient data including medical history, lab results, radialogy images etc among the oncology speclialists. For instance, in May 2023, EU research projects usingbthe AI platform advance and improve patiens care treatments. AI supporting cancer patients across the Europe (ASCAPE) is creating an open AI infrastructure for hospitals and research institutions. The digital infrastructure would provide the services such as intelligence interventions for physical and psychological support, improve patient and family counselling, early diagnosis and monitoring.

<h3>Restraints</h3>

Factors such as data privacy and security concerns, high cost associated with the technologies, limited infrastructure and technology, regulatory &amp; reimbursement issues and lack of skilled professionals are expected to hamper the market.&nbsp;

<h3>Segment Analysis</h3>

The global teleoncology market is segmented based on component, cancer type, application, end-user and region.

The software segment accounted for approximately 56.7% of the teleoncology market share

The software teleoncology segment is expected to hold the largest market share over the forecast period. The growing demand for advanced medical oncology software and teleoncology solutions to enable remote cancer care delivery.&nbsp; Teleoncology enables a more patient-centered approach to cancer care by empowering patients to take an active role in their treatment journey.&nbsp;

Software solutions in the teleoncology market facilitate this by providing patients with access to their medical records, treatment plans, and support resources. This personalized care approach has become increasingly important as patients seek more control over their healthcare decisions.In addition,&nbsp; digital patient engagement tools such as remote monitoring wearable are integrated with teleoncology software to enable patient centric care.

Moreover, major players strategies includes awareness programmes and new product launches drive the segment growth in the market. For instance, in March 2022, Onco Health was introduces a&nbsp;new digital telehealth service for cancer patients.&nbsp;Iris by Onco Health is a personalised, oncology-specific, 24/7 telehealth care system for cancer patients and their families. It integrates human-centered design, mobile technology, data, empathy, and specially trained oncology experts.&nbsp;

Also, in February 2024, Tennessee oncology initiates rural tele health programme to assist middle tennessee cancer patients overcome digital divide. This highlights the critical role of teleoncology software in enabling remote cancer care delivery.

<h3>Geographical Analysis</h3>

North America accounted for approximately 43.1% of the market share&nbsp;

North America region is expected to hold the largest market share over the forecast period. The growth of the market in North America innovations in healthcare, such as teleoncology, seem easier to implement, especially in the U.S.,&nbsp;where an advanced infrastructure supports the system. The integration of teleoncology services into existing healthcare delivery frameworks is supported by this infrastructure.

Governments in North America are proactively supporting the integration of telemedicine, encompassing teleoncology, through diverse policies and initiatives. One significant example is the Centers for Medicare &amp; Medicaid Services (CMS) in the U.S., which has broadened its reimbursement policies for telehealth services. This expansion includes teleoncology, thereby enhancing patient accessibility to these advanced healthcare services.

Furthermore, the use of tele-dermatology services such as Telederm, the U.K,&nbsp;government implemented to diagnose more than 50,000 cases of skin cancer each year without requiring a hospital visit, has enabled cost savings through teleoncology.

Moreover, key players strategies such as partnerships, collaborations and reimbursement regulations propel the teleoncology market in this region. For instance in 2020, the U.S., Centers for Medicare and Medicaid Services change the policy guidelines for telehealth services, including teleoncology. Owing to this changes patients are having more access to the teleoncology, which allow shilled healthcare professionals to be reimbursed for providing remote patient care. The market has grown as a result of this campaign, which has promoted the use of teleoncology services across the nation.

For instance, the Tele-Oncology Resource Centre was established by the American Society of Clinical Oncology (ASCO) to offer tools and advice to medical practitioners whom are considering teleoncology programmes. In the teleoncology market, these alliances and collaborations have promoted innovation and expansion.

<h3>COVID -19 Impact Analysis</h3>

The COVID-19 pandemic significantly impacted the global teleoncology market. Owing to the pandemic, teleoncology services have been employed extensively with the aim to reduce in-person visits and provide remote cancer therapy. Research indicates that during the pandemic, telemedicine was used more frequently for cancer care. At the peak&nbsp;of the pandemic, telemedicine interactions between patients and investigators in cancer clinical trials were reported to have increased six times.

The COVID-19 epidemic and society&#39;s expanding technology are expected to fuel teleoncology market. Preventing more inequality and the growing digital divide have to be the main goals of the healthcare system. In order to lower the risk of infection, telemedicine was utilised to treat cancer patients that had not received medical care previously. According to NCBI research publication, in 2023,&nbsp; a study of 1,097 cancer patients in Nigeria found that 12.6% of their routine follow-up visits were converted to virtual visits owing to COVID-19.

&nbsp;Owing to its rapid adoption, concerns have been expressed about patient preferences and satisfaction as well as possible applications for tele-oncology in the future. In addition, cancer center in the U.S., telehealth use as a proportion of total clinic encounters peaked at 60% during the first wave of the COVID-19 pandemic, closely tracking trends in COVID-19 cases.&nbsp;

Although the use of teleoncology has grown in affluent nations with robust internet infrastructure, many developing nations continue to face obstacles such poor internet connectivity, operational difficulties and regulatory constraints which has limited the use of teleoncology during the epidemic.

<h3>Competitive Landscape</h3>

The major global players in the teleoncology market include Flatiron Health, McKesson Corporation, Oracle, Koninklijke Philips N.V., Varian Medical Systems Inc, Elekta, Accuracy Incorporated, GE HealthCare, Optum, Inc. and American Well among others.&nbsp;

<h3>Key Developments</h3>

<ul>
	<li>On October 2, 2023, The EUCAIM consortium and the European Commission announced the first public release of its platform,&nbsp;Cancer Image Europe, marking a major milestone in the project&rsquo;s development. The first platform release brings benefits to researchers, clinicians and AI innovators across Europe and paves the way for the future of cancer diagnosis and treatment.&nbsp;</li>
	<li>On September 11, 2023, Dell Technologies announced a partnership with University of Limerick to develop an AI platform that uses digital twin technology with cancer patient data to develop diagnosis and facilities. By using this partnership technology would&nbsp;assist medical professionals in providing patients with B-cell lymphoma more effective care by accelerating the diagnosing process, delivering better treatment, and improving long-term results.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global teleoncology market segmentation based on component, cancer type, application, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development</li>
	<li>Excel data sheet with numerous data points of teleoncology market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global teleoncology market report would provide approximately 70 tables, 72 figures and 182 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Component</li>
		<li>Snippet by Cancer Type</li>
		<li>Snipped by Application</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Advancements in the AI and Bigdata Analytics&nbsp;</li>
				<li>Rising Prevalence of Cancer</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Data Privacy and Security Concerns</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
		<li>PESTEL Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During the Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Component</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Component</li>
			<li>Market Attractiveness Index, By Component</li>
		</ol>
		</li>
		<li>Software *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Hardware</li>
		<li>Services</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Cancer Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type</li>
			<li>Market Attractiveness Index, By Cancer Type</li>
		</ol>
		</li>
		<li>Lung Cancer*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Breast Cancer</li>
		<li>Colorectal Cancer</li>
		<li>Prostate Cancer</li>
		<li>Bladder Cancer</li>
		<li>Liver Cancer</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application&nbsp;</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Precision Medicine*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Patient Care Management</li>
		<li>Research &amp; Development</li>
		<li>Clinical Trials</li>
		<li>Diagnosis &amp; Treatment Decision Making</li>
		<li>Data Management</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User&nbsp;</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals &amp; Diagnostics Imaging Centers*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Pharma &amp; Biotech Companies</li>
		<li>Academic and Research Institutes</li>
		<li>Contract Research Organizations</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Component</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Component</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Component</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Component</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Component</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Flatiron Health*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>McKesson Corporation</li>
		<li>Oracle</li>
		<li>Koninklijke Philips N.V.</li>
		<li>Varian Medical Systems Inc</li>
		<li>Elekta</li>
		<li>Accuray Incorporated</li>
		<li>GE HealthCare</li>
		<li>Optum, Inc</li>
		<li>American Well&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Teleoncology Market Value, By Component, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Teleoncology Market Value, By Cancer Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Teleoncology Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Teleoncology Market Value, By End-Use, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Teleoncology Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Teleoncology Market Value, By Component, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Teleoncology Market Value, By Component, 2022-2031 (US$ Million)

Table 8 Global Teleoncology Market Value, By Cancer Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 9 Global Teleoncology Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 10 Global Teleoncology Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 11 Global Teleoncology Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Teleoncology Market Value, By End-Use, 2023, 2027 &amp; 2031 (US$ Million)

Table 13 Global Teleoncology Market Value, By End-Use, 2022-2031 (US$ Million)

Table 14 Global Teleoncology Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 15 Global Teleoncology Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Teleoncology Market Value, By Component, 2022-2031 (US$ Million)

Table 17 North America Teleoncology Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 18 North America Teleoncology Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Teleoncology Market Value, By End-Use, 2022-2031 (US$ Million)

Table 20 North America Teleoncology Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Asia-Pacific Teleoncology Market Value, By Component, 2022-2031 (US$ Million)

Table 22 Asia-Pacific Teleoncology Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 23 Asia-Pacific Teleoncology Market Value, By Application, 2022-2031 (US$ Million)

Table 24 Asia-Pacific Teleoncology Market Value, By End-Use, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Teleoncology Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Teleoncology Market Value, By Component, 2022-2031 (US$ Million)

Table 27 Europe Teleoncology Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 28 Europe Teleoncology Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Teleoncology Market Value, By End-Use, 2022-2031 (US$ Million)

Table 30 Europe Teleoncology Market Value, By Country, 2022-2031 (US$ Million)

Table 31 South America Teleoncology Market Value, By Component, 2022-2031 (US$ Million)

Table 32 South America Teleoncology Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 33 South America Teleoncology Market Value, By Application, 2022-2031 (US$ Million)

Table 34 South America Teleoncology Market Value, By End-Use, 2022-2031 (US$ Million)

Table 35 South America Teleoncology Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East and Africa Teleoncology Market Value, By Component, 2022-2031 (US$ Million)

Table 37 Middle East and Africa Teleoncology Market Value, By Cancer Type, 2022-2031 (US$ Million)

Table 38 Middle East and Africa Teleoncology Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East and Africa Teleoncology Market Value, By End-Use, 2022-2031 (US$ Million)

Table 40 Middle East and Africa Teleoncology Market Value, By Country, 2022-2031 (US$ Million)

Table 41 Flatiron Health: Overview

Table 42 Flatiron Health: Product Portfolio

Table 43 Flatiron Health: Key Developments

Table 44 McKesson Corporation: Overview

Table 45 McKesson Corporation: Product Portfolio

Table 46 McKesson Corporation: Key Developments

Table 47 Oracle: Overview

Table 48 Oracle: Product Portfolio

Table 49 Oracle: Key Developments

Table 50 Koninklijke Philips N.V.: Overview

Table 51 Koninklijke Philips N.V.: Product Portfolio

Table 52 Koninklijke Philips N.V.: Key Developments

Table 53 Varian Medical Systems Inc: Overview

Table 54 Varian Medical Systems Inc: Product Portfolio

Table 55 Varian Medical Systems Inc: Key Developments

Table 56 Elekta: Overview

Table 57 Elekta: Product Portfolio

Table 58 Elekta: Key Developments

Table 59 Accuray Incorporated: Overview

Table 60 Accuray Incorporated: Product Portfolio

Table 61 Accuray Incorporated: Key Developments

Table 62 GE HealthCare: Overview

Table 63 GE HealthCare: Product Portfolio

Table 64 GE HealthCare: Key Developments

Table 65 Optum, Inc: Overview

Table 66 Optum, Inc: Product Portfolio

Table 67 Optum, Inc: Key Developments

Table 68 American Well: Overview

Table 69 American Well: Product Portfolio

Table 70 American Well: Key Developments

List of Figures

Figure 1 Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 2 Global Teleoncology Market Share, By Component, 2023 &amp; 2031 (%)

Figure 3 Global Teleoncology Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 4 Global Teleoncology Market Share, By Application, 2023 &amp; 2031 (%)

Figure 5 Global Teleoncology Market Share, By End-Use, 2023 &amp; 2031 (%)

Figure 6 Global Teleoncology Market Share, By Region, 2023 &amp; 2031 (%)

Figure 7 Global Teleoncology Market Y-o-Y Growth, By Component, 2023-2031 (%)

Figure 8 Software Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 9 Hardware Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 10 Services Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 11 Global Teleoncology Market Y-o-Y Growth, By Cancer Type, 2023-2031 (%)

Figure 12 Lung Cancer Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 13 Breast Cancer Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 14 Colorectal Cancer Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 15 Prostate Cancer Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 16 Bladder Cancer Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 17 Liver Cancer Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 18 &nbsp; Others Cancer Type in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 19 Global Teleoncology Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 20 Precision Medicine Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 21 Patient Care Management Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 22 &nbsp; Research &amp; Development Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 23 Clinical Trials Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 24 Diagnosis &amp; Treatment Decision Making Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 25 Data Management Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 26 Others Application in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 27 Global Teleoncology Market Y-o-Y Growth, By End-Use, 2023-2031 (%)

Figure 28 &nbsp; Hospitals &amp; Diagnostics Imaging Centers End-Use in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 29 Pharma &amp; Biotech Companies End-Use in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 30 Academic and Research Institutes End-Use in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 31 Contract Research Organizations End-Use in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 32 Others End-Use in Global Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 33 Global Teleoncology Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 34 North America Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 35 North America Teleoncology Market Share, By Component, 2023 &amp; 2031 (%)

Figure 36 North America Teleoncology Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 37 North America Teleoncology Market Share, By Application, 2023 &amp; 2031 (%)

Figure 38 North America Teleoncology Market Share, By End-Use, 2023 &amp; 2031 (%)

Figure 39 North America Teleoncology Market Share, By Country, 2023 &amp; 2031 (%)

Figure 40 Asia-Pacific Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 41 Asia-Pacific Teleoncology Market Share, By Component, 2023 &amp; 2031 (%)

Figure 42 Asia-Pacific Teleoncology Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 43 Asia-Pacific Teleoncology Market Share, By Application, 2023 &amp; 2031 (%)

Figure 44 Asia-Pacific Teleoncology Market Share, By End-Use, 2023 &amp; 2031 (%)

Figure 45 Asia-Pacific Teleoncology Market Share, By Country, 2023 &amp; 2031 (%)

Figure 46 Europe Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 47 Europe Teleoncology Market Share, By Component, 2023 &amp; 2031 (%)

Figure 48 Europe Teleoncology Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 49 Europe Teleoncology Market Share, By Application, 2023 &amp; 2031 (%)

Figure 50 Europe Teleoncology Market Share, By End-Use, 2023 &amp; 2031 (%)

Figure 51 Europe Teleoncology Market Share, By Country, 2023 &amp; 2031 (%)

Figure 52 South America Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 53 South America Teleoncology Market Share, By Component, 2023 &amp; 2031 (%)

Figure 54 South America Teleoncology Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 55 South America Teleoncology Market Share, By Application, 2023 &amp; 2031 (%)

Figure 56 South America Teleoncology Market Share, By End-Use, 2023 &amp; 2031 (%)

Figure 57 South America Teleoncology Market Share, By Country, 2023 &amp; 2031 (%)

Figure 58 Middle East and Africa Teleoncology Market Value, 2022-2031 (US$ Million)

Figure 59 Middle East and Africa Teleoncology Market Share, By Component, 2023 &amp; 2031 (%)

Figure 60 Middle East and Africa Teleoncology Market Share, By Cancer Type, 2023 &amp; 2031 (%)

Figure 61 Middle East and Africa Teleoncology Market Share, By Application, 2023 &amp; 2031 (%)

Figure 62 Middle East and Africa Teleoncology Market Share, By End-Use, 2023 &amp; 2031 (%)

Figure 63 Flatiron Health: Financials

Figure 64 McKesson Corporation: Financials

Figure 65 Cerner Cor: Financials

Figure 66 koninklijke Philips N.V.: Financials

Figure 67 Varian Medical Systems Inc: Financials

Figure 68 Elekta: Financials

Figure 69 Accuray Incorporated: Financials

Figure 70 GE Healthcare: Financials

Figure 71 Optum, Inc: Financials

Figure 72 American Well: Financials

Teleoncology Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Oncology Information Systems Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 21

Starting from

Oncology EMR Software Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 October 23

Starting from

Lung Cancer Diagnostics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 11

Starting from